Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
- Substances:AnastrozoleCamizestrant+6
Spain- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Spain28 clinical trials in Leganes, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on respiratory infections and advanced lung cancer treatments. Studies include evaluation of new therapies for non-small cell lung cancer and acute lower respiratory conditions.
Research includes novel combinations of chemotherapy and immunotherapy agents like atezolizumab and sotorasib.
Comprehensive research in breast cancer treatments, particularly focusing on HER2-positive and HER2-negative variants. Multiple trials examining innovative therapeutic approaches.
Studies evaluate new treatment combinations and therapeutic strategies for various breast cancer subtypes.
Investigations into heart failure management and kidney disease treatments, including innovative approaches for chronic renal disease and cardiac resynchronization therapy.
Focus on developing new therapeutic solutions and optimizing existing treatments for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.